Medical Index Frontpage
Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort.



Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort.

BMC Gastroenterol. 2009;9:6

Authors: Clarke G, Fitzgerald P, Cryan JF, Cassidy EM, Quigley EM, Dinan TG

BACKGROUND: Irritable bowel syndrome (IBS) is a common disorder that affects 10-15% of the population. Although characterised by a lack of reliable biological markers, the disease state is increasingly viewed as a disorder of the brain-gut axis. In particular, accumulating evidence points to the involvement of both the central and peripheral serotonergic systems in disease symptomatology.

Read more... [Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort.]
 
Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center.



Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center.

Int J Colorectal Dis. 2009 Aug;24(8):923-9

Authors: Ferenschild FT, Dawson I, de Wilt JH, de Graaf EJ, Groenendijk RP, Tetteroo GW OBJECTIVE: The aim of this study was to review the results and long-term outcome after total mesorectal excision (TME) for adenocarcinoma of the rectum in an unselected population in a community teaching hospital

Read more... [Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center.]
 

« StartPrev12345678910NextEnd »

Page 2 of 101

Journal Search

FeedBurner

Medical Index

Login

Facebook Fan